Wong Li Ping, Edib Zobaida, Alias Haridah, Mohamad Shakir Sharina M, Raja Muhammad Yusoff Raja N A, Sam I-Ching, Zimet Gregory D
a Department of Social and Preventive Medicine, Faculty of Medicine , University of Malaya , Kuala Lumpur , Malaysia.
b Department of Medical Microbiology, Faculty of Medicine , University of Malaya , Kuala Lumpur , Malaysia.
J Obstet Gynaecol. 2017 Oct;37(7):937-943. doi: 10.1080/01443615.2017.1317239. Epub 2017 Jun 22.
Assessing physicians' experiences in HPV vaccine recommendation and delivery to adolescent boys is essential to providing an understanding of the issues of vaccine acceptance and an insight for policymakers to enhance HPV vaccinations among adolescent boys. Between January and April 2014 a mail survey was conducted using physicians in Malaysia known to provide either one or both HPV vaccine (Gardasil and Cervarix) immunisation services. A total of 357 completed questionnaires were received (response rate 22.5%). Of these, 335 physicians see adolescent boys aged 11 to 18 years old in their practice. Only 26.3% (n = 88) recommended the HPV vaccine to these boys. A total of 46.6% (n = 41) have successfully given the HPV vaccine to adolescent boys. A lack of proper guidelines from the health authorities regarding the recommendation of HPV vaccine to the boys (37.2%) and a lack of awareness of the availability of the vaccine for boys (32.8%) were the most commonly cited reasons for non-recommendation. Impact statement Recommending the HPV vaccine for adolescent boys remains a challenge for physicians. Our study provides evidence of challenges and barriers faced by Malaysian physicians who recommend the HPV vaccines (Gardasil and Cervarix) in their practices. In this study, physicians reported HPV vaccine uptake by adolescent boys was very poor. A lack of proper guidelines from the health authorities regarding the recommendation of HPV vaccine to boys and a lack of awareness of the availability of the vaccine for boys were the most commonly cited reasons for non-recommendation. Physicians viewed that support and encouragement from the health authorities are needed to promote the recommendation of the HPV vaccine to adolescent boys. Physicians were also of the opinion that the lay public should be educated about the availability of the HPV vaccine for boys, and its benefits, safety and efficacy, and the high susceptibility of boys to getting HPV infections. The findings provide insights that could be helpful to policymakers or high-level decision-makers of the potential strategies to enhance HPV uptake among adolescent boys.
评估医生在向青少年男性推荐和接种人乳头瘤病毒（HPV）疫苗方面的经验，对于理解疫苗接受问题以及为政策制定者提供见解以提高青少年男性的HPV疫苗接种率至关重要。2014年1月至4月期间，对马来西亚已知提供一种或两种HPV疫苗（加德西和卉妍康）免疫服务的医生进行了邮件调查。共收到357份完整问卷（回复率22.5%）。其中，335名医生在其执业中诊治11至18岁的青少年男性。只有26.3%（n = 88）的医生向这些男孩推荐了HPV疫苗。共有46.6%（n = 41）的医生成功为青少年男性接种了HPV疫苗。卫生当局缺乏关于向男孩推荐HPV疫苗的适当指南（37.2%）以及对男孩可用疫苗缺乏认识（32.8%）是最常被提及的不推荐原因。影响声明 向青少年男性推荐HPV疫苗对医生来说仍然是一项挑战。我们的研究提供了马来西亚医生在其执业中推荐HPV疫苗（加德西和卉妍康）所面临的挑战和障碍的证据。在这项研究中，医生报告青少年男性的HPV疫苗接种率非常低。卫生当局缺乏关于向男孩推荐HPV疫苗的适当指南以及对男孩可用疫苗缺乏认识是最常被提及的不推荐原因。医生认为需要卫生当局的支持和鼓励来促进向青少年男性推荐HPV疫苗。医生还认为应该向公众宣传男孩可用HPV疫苗及其益处、安全性和有效性，以及男孩感染HPV的高易感性。这些发现为政策制定者或高层决策者提供了有关提高青少年男性HPV疫苗接种率的潜在策略的见解，可能会有所帮助。
